N-Methoxy-N-methylisonicotinamide

Catalog No. :
ACRKNF095
CAS No. :
100377-32-0
Molecular Formula :
C8H10N2O2
Molecular Weight :
166.18

IUPAC Name:N-methoxy-N-methylisonicotinamide

N-Methoxy-N-methylisonicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$61.00Login to see priceIn stockIn stock
25g95%$214.00Login to see priceIn stockIn stock
100g95%$816.00Login to see priceIn stockIn stock
500g95%$3153.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methoxy-N-methylisonicotinamide
IUPAC NameN-methoxy-N-methylisonicotinamide
MDL No.MFCD03837728
Molecular FormulaC8H10N2O2
Molecular Weight166.18
SMILESO=C(N(OC)C)C1=CC=NC=C1
InChI KeyZCEFMSGNAOIBOU-UHFFFAOYSA-N
SynonymDTXSID60396835 | F1903-0209 | N-METHOXY-N-METHYLISONICOTINAMIDE | ZCEFMSGNAOIBOU-UHFFFAOYSA-N | N-Methyl-N-methoxyisonicotinamide | SY126558 | AS-65438 | W15433 | AMY27836 | SB54095 | N-methoxy-N-methyl-4-pyridine carboxamide | N-methoxy-N-methyl-4-pyridi
CAS No.100377-32-0
PubChem CID3817473

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRKNF095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLNE518 route compound structure diagram
    ACCLNE5186638-79-5 In Stock
  2. Plus
  3. ACAPOJ750 route compound structure diagram
    ACAPOJ75016887-79-9 In Stock
  4. Then
  5. ACRKNF095 route product structure diagram
    ACRKNF095100377-32-0 In Stock
Inquiry

2. ACRKNF095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLNE518 route compound structure diagram
    ACCLNE5186638-79-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRKNF095 route product structure diagram
    ACRKNF095100377-32-0 In Stock
Inquiry

Comments (0)